14 results match your criteria: "Biocenter N260[Affiliation]"
Front Immunol
September 2021
Psychoneuroimmunology Laboratory, Clinic for Psychosomatic Medicine and Psychotherapy, Justus-Liebig-University Giessen, Giessen, Germany.
The alpha7 nicotinic acetylcholine receptor (Chrna7) plays an essential anti-inflammatory role in immune homeostasis and was recently found on mast cells (MC). Psychosocial stress can trigger MC hyperactivation and increases pro-inflammatory cytokines in target tissues such as the skin. If the cholinergic system (CS) and Chrna7 ligands play a role in these cascades is largely unknown.
View Article and Find Full Text PDFBrain Res
June 2019
Department of Pharmacology, Toxicology, and Pharmacy, University of Veterinary Medicine, Hannover, Germany; Center for Systems Neuroscience, Hannover, Germany. Electronic address:
Chemically or electrically induced status epilepticus (SE) in rodents is a commonly used method for induction of epilepsy. Structural and functional changes in the hippocampus play a pivotal role in epileptogenesis induced by SE. Although cholinergic mechanisms have long been thought to play an important role in the onset and propagation of epileptic seizures, not much is known about the potential role of acetylcholine (ACh) in ictogenesis and epileptogenesis in SE models of temporal lobe epilepsy.
View Article and Find Full Text PDFACS Chem Neurosci
April 2019
Department of Pharmacology , Goethe University Frankfurt , Biocenter N260, Max-von-Laue Str. 9 , 60438 Frankfurt am Main , Germany.
Pathological accumulation of misfolded α-synuclein (α-syn) in the brain plays a key role in the pathogenesis of Parkinson's disease, leading to neuronal dysfunction and motor disorders. The underlying mechanisms linking α-syn aggregations with neurotransmitter disturbance in Parkinson's brains are not well characterized. In the present study, we investigated transgenic mice expressing an aggregation-prone form of full-length human α-syn (h-α-synL62) linked to a signal sequence.
View Article and Find Full Text PDFJ Neurosci Methods
April 2018
Department of Pharmacology, FB 14, Biocenter N260, Max-von-Laue Str. 9, Goethe University Frankfurt, 60438 Frankfurt am Main, Germany. Electronic address:
Microdialysis is a technique that allows access to the extracellular space of many tissues. For behavioural studies, microdialysis probes are inserted into the brain under anesthesia, but the experiment can be done in awake and freely moving animals. Microdialysis is a sampling method (not a measuring method), therefore, the analyte(s) under study must be quantified from the dialysate using available analytical methods of high sensitivity.
View Article and Find Full Text PDFJ Neurochem
December 2015
Department of Pharmacology, School of Pharmacy, Biocenter N260, Goethe University Frankfurt, Frankfurt am Main, Germany.
The lithium-pilocarpine model of status epilepticus is a well-known animal model of temporal lobe epilepsy. We combined this model with in vivo microdialysis to investigate energy metabolites and acute cellular membrane damage during seizure development. Rats were implanted with dialysis probes and pretreated with lithium chloride (127 mg/kg i.
View Article and Find Full Text PDFJ Neurosci Methods
November 2014
Department of Pharmacology, Biocenter N260, Max-von-Laue Str. 9, Goethe University Frankfurt, 60438 Frankfurt am Main, Germany. Electronic address:
Background: Microdialysis is an established technique for collecting small molecular weight substances (e.g. neurotransmitter and energy metabolites) from the extracellular space.
View Article and Find Full Text PDFJ Neurochem
October 2014
Department of Pharmacology, School of Pharmacy, Biocenter N260, Goethe University Frankfurt, Frankfurt am Main, Germany.
The lithium-pilocarpine model is a rat model of epilepsy that mimics status epilepticus in humans. Here, we report changes of acetylcholine (ACh) release in the hippocampus before, during and after status epilepticus as monitored by microdialysis in unanesthetized rats. Administration of pilocarpine (30 mg/kg s.
View Article and Find Full Text PDFNeuropharmacology
April 2014
Department of Pharmacology, College of Pharmacy, Biocenter N260, Goethe University, Max-von-Laue-Str. 9, 60438 Frankfurt am Main, Germany. Electronic address:
The proliferation of astrocytes during early brain development is driven by growth factors and is accompanied by the activation of phospholipase D (PLD). Ethanol disrupts PLD signaling in astrocytes, a process which may contribute to delayed brain growth of fetuses exposed to alcohol during pregnancy. We here report that insulin-like growth factor 1 (IGF-1) is a strong mitogen for rat astrocytes (EC50 0.
View Article and Find Full Text PDFCurr Protein Pept Sci
August 2010
Goethe-University of Frankfurt, Department of Pharmacology,Campus Riedberg, Biocenter N260 R1.09, Max-von-Laue Strasse 9, D-60438 Frankfurt, Germany.
Gradual changes in steady-state levels of beta amyloid peptides (Abeta) in the brain are considered as initial step in the amyloid cascade hypothesis of Alzheimer's disease (AD). Abeta is a product of the secretase cleavage of the amyloid precursor protein and there is evidence that the membrane lipid environment may modulate secretase activity and alters its function. Abeta disturbs membrane properties of artificial and isolated biological membranes and of plasma membranes in living cells.
View Article and Find Full Text PDFMol Neurobiol
June 2010
Department of Pharmacology, Goethe University, Campus Riedberg, Biocenter N260, Max-von-Laue-St. 9, 60438, Frankfurt, Germany.
There is keen interest in the role of the isoprenoids farnesylpyrophosphate (FPP) and geranylgeranylpyrophosphate (GGPP) in protein prenylation and cell function in Alzheimer's disease (AD). We recently reported elevated FPP and GGPP brain levels and increased gene expression of FPP synthase (FPPS) and GGPP synthase (GGPPS) in the frontal cortex of AD patients. Cholesterol levels and gene expression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase were similar in AD and control samples, suggesting that homeostasis of FPP and GGPP but not cholesterol is specifically targeted in brain tissue of AD patients (Neurobiol Dis 2009 35:251-257).
View Article and Find Full Text PDFMol Pharmacol
March 2010
Institute of Pharmacology, Goethe University, Biocenter N260, Max-von-Laue-Str. 9, 60438 Frankfurt, Germany.
The naturally occurring acylated phloroglucinol derivative hyperforin was recently identified as the first specific canonical transient receptor potential-6 (TRPC6) activator. Hyperforin is the major antidepressant component of St. John's wort, which mediates its antidepressant-like properties via TRPC6 channel activation.
View Article and Find Full Text PDFExpert Opin Investig Drugs
July 2007
University of Frankfurt College of Pharmacy, Biocenter N260, Frankfurt, Germany.
Phenserine, a derivative of physostigmine, was first described as an inhibitor of acetylcholinesterase (AChE) and was shown to improve cognition in various experimental paradigms in rodents and dogs. It was clinically tested for Alzheimer's disease, with moderate success in initial Phase II studies. Phenserine deserves attention for an additional quality of action: in addition to inhibiting AChE, it modulates the amount of beta-amyloid precursor protein (APP) in neuronal cell culture by reducing APP translation.
View Article and Find Full Text PDFNeurosci Lett
September 2004
Institute of Pharmacology, J.W. Goethe-University, Biocenter N260, Marie-Curie-Strasse 9, 60439 Frankfurt, Germany.
Hyperforin, the major active constituent of St. John Wort (SJW) extract, affects several neurotransmitter systems in the brain putatively by modulation of the physical state of neuronal membranes. Accordingly, we tested the effects of SJW extract and of hyperforin on the properties of murine brain membrane fluidity.
View Article and Find Full Text PDFJ Nutr Health Aging
September 2003
Department of Pharmacology, Biocenter N260, Marie-Curie-Str 9, 60439 Frankfurt, Germany.
Cholesterol represents an important determinant of the physical state of biological membranes. Growing evidence indicate that changes in brain cholesterol and variations in neuronal membrane structure are involved in the development of Alzheimer's disease (AD). Cholesterol modulates the cleavage of the amyloid precursor protein and thus affect cellular production of beta-amyloid peptides (Ab).
View Article and Find Full Text PDF